• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

F-氟雌二醇PET在转移性乳腺癌中的诊断和预后作用：一个古老的治疗诊断概念的新活力

Diagnostic and Prognostic Role of F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept.

作者信息

Fiz Francesco, Bottoni Gianluca, Treglia Giorgio, Trimboli Pierpaolo, Piccardo Arnoldo

机构信息

Nuclear Medicine Department, E.O. "Ospedali Galliera", 16128 Genoa, Italy.

Clinic of Nuclear Medicine, Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, 6500 Bellinzona, Switzerland.

出版信息

J Clin Med. 2022 Jun 22;11(13):3589. doi: 10.3390/jcm11133589.

DOI:10.3390/jcm11133589
PMID:35806878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9267420/
Abstract

Since the discovery of the role of female hormones in breast cancer (BC) pathophysiology, in vivo detection of oestrogen receptor (ER) distribution has been one of the major goals of nuclear medicine and molecular imaging [...].

摘要

自从发现女性激素在乳腺癌（BC）病理生理学中的作用以来，雌激素受体（ER）分布的体内检测一直是核医学和分子成像的主要目标之一[...]。

相似文献

1
Diagnostic and Prognostic Role of F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept.F-氟雌二醇PET在转移性乳腺癌中的诊断和预后作用：一个古老的治疗诊断概念的新活力
J Clin Med. 2022 Jun 22;11(13):3589. doi: 10.3390/jcm11133589.
2
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.骨转移的异质性是影响雌激素受体阳性乳腺癌患者预后的一个重要因素。联合应用 [18F] 氟雌二醇 PET/CT 和 [18F] 氟脱氧葡萄糖 PET/CT 的作用。
Eur J Radiol. 2021 Aug;141:109821. doi: 10.1016/j.ejrad.2021.109821. Epub 2021 Jun 10.
3
18F-Fluoroestradiol PET in the evaluation of probable oligometastatic breast cancer.18F-氟雌二醇 PET 在评估可能的寡转移性乳腺癌中的应用。
J Med Imaging Radiat Oncol. 2021 Jun;65(3):333-334. doi: 10.1111/1754-9485.13136. Epub 2020 Dec 26.
4
Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET.患者间和患者内（部位间）的雌激素受体结合的变异性，通过 18F-氟雌二醇 PET 进行体内测量。
J Nucl Med. 2011 Oct;52(10):1541-9. doi: 10.2967/jnumed.111.091439. Epub 2011 Sep 8.
5
Diagnostic accuracy and safety of 16α-[F]fluoro-17β-oestradiol PET-CT for the assessment of oestrogen receptor status in recurrent or metastatic lesions in patients with breast cancer: a prospective cohort study.16α-[F]氟-17β-雌二醇 PET-CT 评估乳腺癌复发或转移病灶中雌激素受体状态的诊断准确性和安全性：一项前瞻性队列研究。
Lancet Oncol. 2019 Apr;20(4):546-555. doi: 10.1016/S1470-2045(18)30936-7. Epub 2019 Mar 4.
6
Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies.转移性乳腺癌患者雄激素和雌激素受体成像作为组织活检的替代方法
J Nucl Med. 2017 Dec;58(12):1906-1912. doi: 10.2967/jnumed.117.193649. Epub 2017 Sep 14.
7
F-Fluoroestradiol PET Imaging of Activating Estrogen Receptor-α Mutations in Breast Cancer.F-氟雌二醇 PET 显像在乳腺癌激活型雌激素受体-α突变中的应用。
J Nucl Med. 2019 Sep;60(9):1247-1252. doi: 10.2967/jnumed.118.224667. Epub 2019 Mar 8.
8
The Predictive Value of Early Changes in F-Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.氟[18F]雌二醇正电子发射断层扫描/计算机断层扫描在氟维司群 500mg 治疗雌激素受体阳性转移性乳腺癌患者中早期变化的预测价值。
Oncologist. 2020 Nov;25(11):927-936. doi: 10.1634/theoncologist.2019-0561. Epub 2020 Apr 28.
9
Comparison of diagnostic sensitivity of [F]fluoroestradiol and [F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer.[F]氟雌二醇与[F]氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对雌激素受体阳性原发性乳腺癌病史患者乳腺癌复发的诊断敏感性比较。
EJNMMI Res. 2020 May 24;10(1):54. doi: 10.1186/s13550-020-00643-z.
10
Can F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with F-Fluorodeoxyglucose Positron Emission Tomography?氟-雌二醇正电子发射断层扫描能否成为雌激素受体阳性乳腺癌患者的新成像标准：与氟-脱氧葡萄糖正电子发射断层扫描的前瞻性对比研究？
World J Nucl Med. 2017 Apr-Jun;16(2):133-139. doi: 10.4103/1450-1147.203071.

本文引用的文献

1
Clinical Validity of 16α-[F]Fluoro-17β-Estradiol Positron Emission Tomography/Computed Tomography to Assess Estrogen Receptor Status in Newly Diagnosed Metastatic Breast Cancer.16α-[F]氟-17β-雌二醇正电子发射断层扫描/计算机断层扫描评估新诊断转移性乳腺癌雌激素受体状态的临床有效性。
J Clin Oncol. 2022 Nov 1;40(31):3642-3652. doi: 10.1200/JCO.22.00400. Epub 2022 May 18.
2
Head-to-Head Comparison between F-FES PET/CT and F-FDG PET/CT in Oestrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-Analysis.F-FES PET/CT与F-FDG PET/CT在雌激素受体阳性乳腺癌中的头对头比较：一项系统评价和荟萃分析
J Clin Med. 2022 Mar 30;11(7):1919. doi: 10.3390/jcm11071919.
3
The Future Role of PET Imaging in Metastatic Breast Cancer.PET 成像在转移性乳腺癌中的未来作用。
Oncol Res Treat. 2022;45(1-2):18-25. doi: 10.1159/000521079. Epub 2021 Nov 24.
4
Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis.F-18 氟雌二醇正电子发射断层扫描/计算机断层扫描的安全性和有效性：系统评价和荟萃分析。
J Korean Med Sci. 2021 Nov 1;36(42):e271. doi: 10.3346/jkms.2021.36.e271.
5
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F]Fluorodeoxyglucose PET/CT.骨转移的异质性是影响雌激素受体阳性乳腺癌患者预后的一个重要因素。联合应用 [18F] 氟雌二醇 PET/CT 和 [18F] 氟脱氧葡萄糖 PET/CT 的作用。
Eur J Radiol. 2021 Aug;141:109821. doi: 10.1016/j.ejrad.2021.109821. Epub 2021 Jun 10.
6
Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects.乳腺癌细胞中雌激素受体 α 突变通过持续活性和次级效应引起基因表达变化。
Cancer Res. 2021 Feb 1;81(3):539-551. doi: 10.1158/0008-5472.CAN-20-1171. Epub 2020 Nov 12.
7
Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.原发与转移性乳腺癌中雌激素、孕激素和人表皮生长因子受体 2 的不一致性。
Breast Cancer Res Treat. 2020 Aug;183(1):137-144. doi: 10.1007/s10549-020-05746-8. Epub 2020 Jul 1.
8
Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications.16α-18F-氟-17β-雌二醇正电子发射断层扫描全身特征在转移性乳腺癌中雌激素受体状态的评估：荟萃分析和纳入临床应用的建议。
Oncologist. 2020 Oct;25(10):835-844. doi: 10.1634/theoncologist.2019-0967. Epub 2020 May 15.
9
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.通过功能成像改善乳腺癌管理的探索：16α-[F]氟雌二醇（FES）的发现和发展，一种用于雌激素受体的 PET 放射性示踪剂，历史回顾。
Nucl Med Biol. 2021 Jan;92:24-37. doi: 10.1016/j.nucmedbio.2020.02.007. Epub 2020 Feb 22.
10
Assessment of the impact of 2015 American Thyroid Association guidelines in management of differentiated thyroid cancer patients.2015年美国甲状腺协会指南对分化型甲状腺癌患者管理的影响评估
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):547-553. doi: 10.1007/s00259-019-04582-3. Epub 2019 Nov 9.